27d agoThe FlyBEARISH 38Analyst
Archived explainer. For the current picture see today's LEGN page.
Why Is LEGEND BIOTECH CORP ADR (LEGN) Stock Up Today?
By the Top Tier Newswire AI Desk · August 18, 2026 at 2:24 PM ET · reviewed against 3 wire stories
LEGEND BIOTECH CORP ADR (LEGN) is up +5.78% in the latest session. Our newswire has captured 3 stories on LEGN across 1 source in the last 36 hours, with AI sentiment reading bearish (avg 39/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Why LEGN stock is up today
Legend Biotech Corp ADR (LEGN) rose 5.78% to $21.84 in afternoon trading on Monday, driven by a mix of analyst activity and broader market dynamics. The stock opened with a small gap down but quickly reversed to post a strong intraday gain. Multiple analyst firms adjusted their ratings and price targets in the past 36 hours, contributing to the stock's upward momentum.
What Happened
Three separate analyst actions were reported in the past 36 hours, each reflecting a cautious stance on the stock. Oppenheimer downgraded the stock to Perform, citing CEO and competitive concerns. TD Cowen and Barclays both reduced their price targets, with TD Cowen cutting it to $24 from $29 and Barclays lowering it to $78 from $80. These moves suggest a recalibration of expectations for Legend Biotech. Meanwhile, Morgan Stanley raised its price target to $49 and RBC Capital maintained an Outperform rating but reduced its target to $58. The mixed analyst commentary appears to have spurred a buying response from investors.
What The Data Shows
The stock opened at $20.54, slightly below the prior close of $20.65, and traded as low as $20.43 before recovering to a session high of $21.90. Volume was 1.6 million shares, which is 0.6 times the 3-month average. Over the past eight sessions, the stock has gained 5.9% from $19.05 to $20.18. Recent insider transactions include two sales totaling $171K, with the most recent filing on July 2. The stock also printed five fresh 52-week lows on August 18, indicating a volatile price environment.
What To Watch
The stock is currently unprofitable with a TTM net margin of -22.0% and a beta of 0.39. Investors will want to monitor the breadth of analyst coverage and any upcoming earnings reports for further direction.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
LEGN by the numbers
Last: $21.84Session: +5.78%7 sessions: +7.35%Coverage: 3 stories / 1 sourcesAI sentiment: 39/100 (bearish)Mkt cap: $3.7B52w: $16.24 to $38.35
The headlines behind the move
27d agoThe FlyBEARISH 42Analyst
Legend Biotech price target lowered to $78 from $80 at Barclays
27d agoThe FlyBEARISH 38Analyst
Oppenheimer downgrades Legend Biotech to Perform on CEO/competition overhangs
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on LEGN: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier LEGN move explainers: 2026-08-18